Geneos Wealth Management’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.81M Buy
172,766
+2,819
+2% +$166K 0.23% 97
2025
Q4
$9.3M Buy
169,947
+25,077
+17% +$1.36M 0.23% 110
2025
Q3
$7.74M Buy
144,870
+3,938
+3% +$198K 0.2% 132
2025
Q2
$6.8M Sell
140,932
-103,659
-42% -$4.66M 0.17% 154
2025
Q1
$10.7M Buy
244,591
+131,784
+117% +$5.72M 0.15% 162
2024
Q4
$4.72M Buy
112,807
+4,553
+4% +$202K 0.17% 146
2024
Q3
$4.96M Buy
108,254
+3,416
+3% +$147K 0.19% 132
2024
Q2
$4.47M Sell
104,838
-3,527
-3% -$148K 0.2% 119
2024
Q1
$4.45M Sell
108,365
-5,270
-5% -$210K 0.2% 128
2023
Q4
$4.57M Sell
113,635
-11,969
-10% -$462K 0.23% 115
2023
Q3
$4.77M Buy
125,604
+1,084
+0.9% +$42.9K 0.25% 112
2023
Q2
$4.93M Buy
124,520
+116,910
+1,536% +$4.6M 0.26% 100
2023
Q1
$300K Sell
7,610
-93,940
-93% -$3.74M 0.02% 553
2022
Q4
$3.85M Buy
101,550
+4,976
+5% +$184K 0.23% 117
2022
Q3
$3.37M Sell
96,574
-3,012
-3% -$118K 0.23% 107
2022
Q2
$3.97M Buy
99,586
+1,916
+2% +$80.4K 0.2% 122
2022
Q1
$4.41M Sell
97,670
-6,550
-6% -$309K 0.19% 130
2021
Q4
$5.18M Buy
104,220
+499
+0.5% +$25.1K 0.2% 116
2021
Q3
$5.22M Buy
103,721
+2,583
+3% +$134K 0.2% 118
2021
Q2
$5.54M Buy
101,138
+5,326
+6% +$289K 0.22% 104
2021
Q1
$5.17M Buy
95,812
+29
+0% +$1.59K 0.14% 168
2020
Q4
$5.08M Buy
95,783
+33,891
+55% +$1.63M 0.2% 118
2020
Q3
$2.66M Sell
61,892
-1,713
-3% -$75.2K 0.14% 167
2020
Q2
$2.54M Buy
63,605
+39,340
+162% +$1.47M 0.14% 160
2020
Q1
$809K Sell
24,265
-1,287
-5% -$52.8K 0.05% 284
2019
Q4
$1.15M Buy
25,552
+556
+2% +$23.9K 0.06% 273
2019
Q3
$1.01M Sell
24,996
-1,888
-7% -$77.9K 0.06% 265
2019
Q2
$1.15M Buy
26,884
+1,356
+5% +$57.6K 0.07% 247
2019
Q1
$1.09M Buy
25,528
+4,585
+22% +$193K 0.07% 262
2018
Q4
$821K Buy
20,943
+597
+3% +$23.9K 0.06% 279
2018
Q3
$873K Buy
20,346
+1,051
+5% +$45.4K 0.06% 286
2018
Q2
$837K Sell
19,295
-7,069
-27% -$327K 0.07% 252
2018
Q1
$1.27M Sell
26,364
-1,577
-6% -$77.3K 0.11% 178
2017
Q4
$1.32M Buy
27,941
+2,616
+10% +$121K 0.12% 173
2017
Q3
$1.15M Sell
25,325
-164
-0.6% -$7.22K 0.11% 177
2017
Q2
$1.05M Buy
25,489
+3,773
+17% +$154K 0.11% 179
2017
Q1
$894K Buy
21,716
+6,343
+41% +$241K 0.09% 187
2016
Q4
$538K Buy
15,373
+3,259
+27% +$118K 0.07% 233
2016
Q3
$453K Buy
12,114
+1,797
+17% +$65.7K 0.06% 262
2016
Q2
$357K Sell
10,317
-1,553
-13% -$52.1K 0.05% 312
2016
Q1
$405K Buy
+11,870
New +$368K 0.06% 274

Other funds holding EEM

Geneos Wealth Management's EEM Position: Q1 2026 in Review

Geneos Wealth Management increased its iShares MSCI Emerging Markets ETF (EEM) stake by 1.7% in Q1 2026, buying an estimated $166K and bringing the position to 172,766 shares worth $9.81M. The position accounts for 0.23% of the portfolio, ranked #97.

Geneos Wealth Management first reported a position in EEM in Q1 2016 and has held it in 41 quarters since. The position peaked at $10.7M in Q1 2025. 1,608 funds tracked by Wall St. Rank hold EEM as of Q1 2026.

  • Geneos Wealth Management held 172,766 shares of iShares MSCI Emerging Markets ETF worth $9.81M as of Q1 2026.
  • Geneos Wealth Management bought 2,819 iShares MSCI Emerging Markets ETF shares in Q1 2026, an estimated $166K.
  • iShares MSCI Emerging Markets ETF made up 0.23% of Geneos Wealth Management's portfolio in Q1 2026, its #97 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI Emerging Markets ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares MSCI Emerging Markets ETF position peaked at $10.7M in Q1 2025.
  • 1,608 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.